LOADING
Comparing NVIDIA Corporation (NVDA) and AbbVie Inc (ABBV) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | ABBV |
|---|---|---|
| Price | $208.27 | $198.71 |
| Change Today | +4.32% | -1.11% |
| Market Cap | -- | $355.4B |
| P/E Ratio | -- | 84.8 |
| Forward P/E | -- | 14.2 |
| PEG Ratio | -- | 0.47 |
| EPS | -- | $2.37 |
| Revenue Growth (YoY) | -- | 10.0% |
| Profit Margin | -- | 6.9% |
| Return on Equity | -- | 62.3% |
| Dividend Yield | -- | 3.32% |
| Beta | -- | 0.36 |
| 52-Week High | -- | $239.13 |
| 52-Week Low | -- | $171.00 |
| Volume | 214.1M | 7.6M |